- Home
- ENTG vs ROIV Comparison
ENTG vs ROIV Comparison
Compare ENTG & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTG
- ROIV
- Stock Information
- Founded
- ENTG 1966
- ROIV 2014
- Country
- ENTG United States
- ROIV United Kingdom
- Employees
- ENTG N/A
- ROIV N/A
- Industry
- ENTG Plastic Products
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ENTG Industrials
- ROIV Health Care
- Exchange
- ENTG Nasdaq
- ROIV Nasdaq
- Market Cap
- ENTG 13.9B
- ROIV 14.0B
- IPO Year
- ENTG 2000
- ROIV N/A
- Fundamental
- Price
- ENTG $85.73
- ROIV $20.63
- Analyst Decision
- ENTG Buy
- ROIV Strong Buy
- Analyst Count
- ENTG 11
- ROIV 8
- Target Price
- ENTG $107.09
- ROIV $21.06
- AVG Volume (30 Days)
- ENTG 2.3M
- ROIV 8.8M
- Earning Date
- ENTG 10-30-2025
- ROIV 11-10-2025
- Dividend Yield
- ENTG 0.46%
- ROIV N/A
- EPS Growth
- ENTG 26.59
- ROIV N/A
- EPS
- ENTG 1.90
- ROIV N/A
- Revenue
- ENTG $3,222,508,000.00
- ROIV $23,233,000.00
- Revenue This Year
- ENTG $0.33
- ROIV N/A
- Revenue Next Year
- ENTG $6.33
- ROIV $320.50
- P/E Ratio
- ENTG $45.63
- ROIV N/A
- Revenue Growth
- ENTG 0.59
- ROIV N/A
- 52 Week Low
- ENTG $60.75
- ROIV $8.73
- 52 Week High
- ENTG $112.36
- ROIV $20.77
- Technical
- Relative Strength Index (RSI)
- ENTG 43.89
- ROIV 82.87
- Support Level
- ENTG $86.14
- ROIV $19.30
- Resistance Level
- ENTG $90.47
- ROIV $20.09
- Average True Range (ATR)
- ENTG 3.94
- ROIV 0.61
- MACD
- ENTG -0.81
- ROIV 0.10
- Stochastic Oscillator
- ENTG 24.50
- ROIV 94.27
About ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.